Monday, June 21, 2010

Incline Therapeutics Gets $43M

Redwood City-based Incline Therapeutics, a specialty pharmaceuticals firm developing a transdermal, patient-controlled analgesia system for post-surgey patients, has scored $43M in a Series A venture financing. The firm said Monday that the deal also includes an agreement which gives Cadence Pharmaceuticals an exclusive option to acquire Incline Therapeutics.The $43M in equity funding came from Frazier Healthcare Ventures, 5AM Ventures, Technology Partners, Adams Street Partners, Saints Capital Partners and Emergent Medical Partners. Incline's products are based on the rights to the IONSYS (fentanyl iontophoretic transdermal system) from ALZA Corporation, which it acquired in conjunction with the funding. More information »